Effect of random deferral of percutaneous coronary intervention in patients with diabetes and stable ischaemic heart disease

被引:4
|
作者
Williams, Conor [1 ]
Brown, David L. [2 ]
机构
[1] Washington Univ, Dept Med, St Louis, MO USA
[2] Washington Univ, Cardiovasc Div, St Louis, MO 63110 USA
关键词
cardiac catheterisation and angiography; percutaneous coronary intervention; chronic coronary disease; FRACTIONAL FLOW RESERVE; OPTIMAL MEDICAL THERAPY; ARTERY-DISEASE; MYOCARDIAL-ISCHEMIA; FUNCTIONAL SEVERITY; REVASCULARIZATION; OUTCOMES; ANGIOGRAPHY; EXERCISE; ECHOCARDIOGRAPHY;
D O I
10.1136/heartjnl-2019-316432
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In stable ischaemic heart disease (SIHD), measurement of fractional flow reserve (FFR) to guide selection of lesions for percutaneous coronary intervention (PCI) reduces death and myocardial infarction (MI) compared with angiographic guidance. However, it is unknown if the improved outcomes are due to avoidance of stenting of physiologically insignificant lesions or are a by-product of placing fewer stents. Methods We developed a Monte Carlo simulation using the PCI strata of the Bypass Angioplasty Revascularization Investigation 2 Diabetes study to investigate how random deferral of PCI impacts outcomes. To simulate deferral, a randomly selected group of patients randomised to PCI were removed and replaced by an equal number of randomly selected patients randomised to intensive medical therapy (IMT) using a random number generator in Python's NumPy module. The primary endpoint was the rate of death or non-fatal MI at 1 year. Results Death/MI at 1 year occurred in 8.3% of 798 patients in the PCI group and 5.1% of 807 patients in the IMT control group (p=0.02). Following 10 000 iterations of random replacement of 10%, 20%, 30% or 40% of PCI patients with randomly selected IMT patients, the rate of death/MI at 1 year progressively declined from 8.3% to 8.0%, 7.6%, 7.3% and 7.0%, respectively. Conclusions In this simulation model, random deferral of PCI procedures in SIHD progressively reduced death/MI as the percentage of procedures deferred increases. FFR-guided deferral of PCI may improve outcomes as a result of placing fewer stents and be unrelated to the haemodynamic severity of lesions.
引用
收藏
页码:1651 / +
页数:7
相关论文
共 50 条
  • [1] Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease
    Francisco Ujueta
    Ephraim N. Weiss
    Binita Shah
    Steven P. Sedlis
    [J]. Current Cardiology Reports, 2017, 19
  • [2] Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease
    Ujueta, Francisco
    Weiss, Ephraim N.
    Shah, Binita
    Sedlis, Steven P.
    [J]. CURRENT CARDIOLOGY REPORTS, 2017, 19 (02)
  • [3] The role of percutaneous coronary intervention in managing patients with stable ischemic heart disease
    Herbert, Tara
    Rizzolo, Denise
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2020, 33 (06): : 18 - 23
  • [4] Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia
    Hamilton, Garry W.
    Yeoh, Julian
    Dinh, Diem
    Reid, Christopher M.
    Yudi, Matias B.
    Freeman, Melanie
    Brennan, Angela
    Stub, Dion
    Oqueli, Ernesto
    Sebastian, Martin
    Duffy, Stephen J.
    Horrigan, Mark
    Farouque, Omar
    Ajani, Andrew
    Clark, David J.
    [J]. HEART LUNG AND CIRCULATION, 2022, 31 (12): : 1619 - 1629
  • [5] Percutaneous coronary intervention for the management of stable ischemic heart disease
    Liu, Shuangbo
    Tsang, Michael
    Abdel-Qadir, Husam
    Yanagawa, Bobby
    Bagai, Akshay
    [J]. CURRENT OPINION IN CARDIOLOGY, 2019, 34 (05) : 557 - 563
  • [6] Curcumin's Effect on Inflammatory Response following Percutaneous Coronary Intervention in Adult Patients with Stable Coronary Heart Disease
    Silalahi, Todung
    Alwi, Idrus
    Suyatna, Frans
    Sartika, Katarina D.
    [J]. INTERNATIONAL JOURNAL OF ANGIOLOGY, 2021, 30 (02) : 132 - 138
  • [7] Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease
    Weintraub, William S.
    Boden, William E.
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (08) : 1190 - 1194
  • [8] High-Risk Percutaneous Coronary Intervention in Patients With Stable Ischemic Heart Disease
    Weintraub, William S.
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2019, 20 (04) : 269 - 270
  • [9] Percutaneous Coronary Intervention in Stable Coronary Heart Disease-Is Less More?
    Figulla, Hans R.
    Lauten, Alexander
    Maier, Lars S.
    Sechtem, Udo
    Silber, Sigmund
    Thiele, Holger
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (09): : 137 - 144
  • [10] Effect of percutaneous coronary intervention on heart rate recovery in patients with coronary artery disease
    Liu, Jianguo
    Xu, Aibin
    Niu, Lili
    Li, Junxia
    [J]. CORONARY ARTERY DISEASE, 2015, 26 (05) : 442 - 447